Tivozanib Publications & Presentations | AVEO Oncology

Publications and presentations

AVEO Oncology allows you to access a number of published papers and presentations outlining our clinical data that were given at premier conferences and symposia around the world.

June 7, 2010
PresentationTivozanib

ASCO 2010: Activity of Tivozanib (AV-951) in Patients With Renal Cell Carcinoma (RCC): Subgroup Analysis From a Phase 2 Randomized Discontinuation Trial (RDT)

March 5, 2010
PresentationTivozanib

ASCO GU 2010: Effect of hypertension, nephrectomy and prior treatment on the efficacy of tivozanib (AV-951) in a phase 2 randomized discontinuation trial (RDT) in patients with renal cell carcinoma (RCC)

1 … 10 11 12

Looking for medical information? Contact our Medical Information Team at

AVEOmedicalinformation@aveooncology.com.